16-28878386-CA-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The ENST00000691192.2(ATP2A1-AS1):n.1550del variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.34 ( 9453 hom., cov: 0)
Exomes 𝑓: 0.35 ( 20120 hom. )
Consequence
ATP2A1-AS1
ENST00000691192.2 non_coding_transcript_exon
ENST00000691192.2 non_coding_transcript_exon
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.00
Genes affected
ATP2A1-AS1 (HGNC:51370): (ATP2A1 antisense RNA 1)
ATP2A1 (HGNC:811): (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1) This gene encodes one of the SERCA Ca(2+)-ATPases, which are intracellular pumps located in the sarcoplasmic or endoplasmic reticula of muscle cells. This enzyme catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol to the sarcoplasmic reticulum lumen, and is involved in muscular excitation and contraction. Mutations in this gene cause some autosomal recessive forms of Brody disease, characterized by increasing impairment of muscular relaxation during exercise. Alternative splicing results in three transcript variants encoding different isoforms. [provided by RefSeq, Oct 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 16-28878386-CA-C is Benign according to our data. Variant chr16-28878386-CA-C is described in ClinVar as [Benign]. Clinvar id is 1178419.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.397 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATP2A1-AS1 | ENST00000691192.2 | n.1550del | non_coding_transcript_exon_variant | 1/1 | |||||
ATP2A1 | ENST00000357084.7 | upstream_gene_variant | 2 | A1 |
Frequencies
GnomAD3 genomes AF: 0.340 AC: 51639AN: 151678Hom.: 9424 Cov.: 0
GnomAD3 genomes
AF:
AC:
51639
AN:
151678
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.345 AC: 107406AN: 311030Hom.: 20120 Cov.: 0 AF XY: 0.336 AC XY: 55591AN XY: 165486
GnomAD4 exome
AF:
AC:
107406
AN:
311030
Hom.:
Cov.:
0
AF XY:
AC XY:
55591
AN XY:
165486
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.341 AC: 51733AN: 151796Hom.: 9453 Cov.: 0 AF XY: 0.339 AC XY: 25138AN XY: 74186
GnomAD4 genome
AF:
AC:
51733
AN:
151796
Hom.:
Cov.:
0
AF XY:
AC XY:
25138
AN XY:
74186
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
953
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 14, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at